| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/23/2010 | WO2010148212A2 Short telomere length on chromosome 9p is strongly associated with breast cancer risk |
| 12/23/2010 | WO2010148145A1 Methods and kits for detecting ovarian cancer from blood |
| 12/23/2010 | WO2010148135A2 Harvesting target materials from centrifuged suspensions |
| 12/23/2010 | WO2010148130A1 Method for measuring lipoprotein-specific apolipoproteins |
| 12/23/2010 | WO2010148115A1 Methods, systems and kits for detecting protein-nucleic acid interactions |
| 12/23/2010 | WO2010148036A1 Identification and assessment of memory modulating compounds |
| 12/23/2010 | WO2010148020A2 Detection of occult blood in feces or urine |
| 12/23/2010 | WO2010148017A1 Determination of coronary artery disease risk. |
| 12/23/2010 | WO2010147998A2 Quenched fluorophores conjugated to peptides via linkers containing dithio groups |
| 12/23/2010 | WO2010147961A1 Methods and markers for predicting responses to chemotherapy |
| 12/23/2010 | WO2010147958A2 Robot for orchestrating microfluidics experiments |
| 12/23/2010 | WO2010147952A1 Methylated arginine metabolites as risk predictors of cardiovascular disease |
| 12/23/2010 | WO2010147918A2 Detection of acid-producing bacteria |
| 12/23/2010 | WO2010147601A1 Use of methylation status of mint loci as a marker for rectal cancer |
| 12/23/2010 | WO2010147375A2 Method for screening for substance which inhibits interaction between beta amyloid peptide and vegf and inhibitor searched by same |
| 12/23/2010 | WO2010147274A1 Secretory granules and granulogenic factors as a target for cancer treatment |
| 12/23/2010 | WO2010147273A2 Method for screening agents to treat reproductive function disorders caused by alcohol exposure |
| 12/23/2010 | WO2010147251A1 Method for measuring glycated hemoglobin |
| 12/23/2010 | WO2010147208A1 Standard treatment sheet and method for determining treatment method for detoxification of asbestos-containing material |
| 12/23/2010 | WO2010147206A1 Method for evaluating oxidation stress and use of the same |
| 12/23/2010 | WO2010147167A1 Method for positioning of probe in microarray |
| 12/23/2010 | WO2010147166A1 Optical reaction measurement device and optical reaction measurement method |
| 12/23/2010 | WO2010147146A1 Method for detecting target cell |
| 12/23/2010 | WO2010147117A1 Peptide and use thereof |
| 12/23/2010 | WO2010146758A1 Fluorescent analysis method |
| 12/23/2010 | WO2010146592A2 Method for the diagnosis of pathological conditions in animals |
| 12/23/2010 | WO2010146588A2 Miniature disease diagnostic system |
| 12/23/2010 | WO2010146563A1 Device having self-assembled-monolayer |
| 12/23/2010 | WO2010146367A1 Fluid sensing, sensor apparatus for fluid sensing, fluid sensing systems and fluid sensing methods |
| 12/23/2010 | WO2010146366A1 Assays relating to biomimetic membranes and their uses |
| 12/23/2010 | WO2010146211A1 Organotipic model of neurodegenerative diseases, production method and uses thereof |
| 12/23/2010 | WO2010146186A1 Method for the prediction of the severity of nuclear envelope-related diseases. |
| 12/23/2010 | WO2010146184A1 Novel method for isolating trichinella or other parasites from organic tissue |
| 12/23/2010 | WO2010146182A1 Method for monitoring the effect of ace inhibitor therapy on peripheral insulin resistance |
| 12/23/2010 | WO2010146181A1 Therapeutic effects of ace inhibitors in patients with diabetes mellitus |
| 12/23/2010 | WO2010146164A1 Fluorogenic peptidase substrate |
| 12/23/2010 | WO2010146152A2 Device for performing an affinity chromatographic sample test |
| 12/23/2010 | WO2010146123A1 Blood filter and method for filtering blood |
| 12/23/2010 | WO2010146064A1 Diagnostical use of peroxiredoxin 4 |
| 12/23/2010 | WO2010146055A1 Antagonists of beta-catenin for preventing and/or treating neurodegenerative disorders |
| 12/23/2010 | WO2010145880A1 Means and methods for diagnosing a diabetes mellitus associated kidney damage in individuals in need of a suitable therapy |
| 12/23/2010 | WO2010145851A1 Device for the measurement of electrical properties of fluids and method for measuring said electrical properties. |
| 12/23/2010 | WO2010145824A1 Detection device for in vivo and/or in vitro enrichment of sample material |
| 12/23/2010 | WO2010145809A1 Methods for operating a spectrometer for gas analysis, and said spectrometer |
| 12/23/2010 | WO2010145796A2 Biomarkers and methods for determining efficacy of anti-egfr antibodies in cancer therapy |
| 12/23/2010 | WO2010145696A1 Methods for detecting the presence or absence of blood |
| 12/23/2010 | WO2010145693A1 Predictive evaluation of the response to taxane-including chemotherapy |
| 12/23/2010 | WO2010145173A1 Reagent kit for detecting anti-moesin antibodies |
| 12/23/2010 | WO2010145035A1 Renal cell carcinoma biomarkers |
| 12/23/2010 | WO2010145029A1 Hinged cap for diagnostic device |
| 12/23/2010 | WO2010145000A1 Biomarker of sarcomas |
| 12/23/2010 | WO2010127264A3 HNF4α ANTAGONISTS AND METHODS OF USE |
| 12/23/2010 | WO2010125333A3 Electrochemical sensor |
| 12/23/2010 | WO2010121163A3 Fluorescent imaging with substituted cyanine dyes |
| 12/23/2010 | WO2010117212A3 Cell sensor, and monitoring method using same for the real-time monitoring of cell capacitance |
| 12/23/2010 | WO2010117198A3 Production process of gender-specific serum and biomarker using the serum |
| 12/23/2010 | WO2010103388A8 Methods using axl as a biomarker of epithelial-to-mesnchymal transition |
| 12/23/2010 | WO2010095298A3 Chemical substance concentration method |
| 12/23/2010 | WO2010093450A3 Pten phosphorylation-driven restistance to cancer treatment and altered prognosis |
| 12/23/2010 | WO2010090542A3 Antibacterial phage, phage peptides and methods of use thereof |
| 12/23/2010 | WO2010083463A9 Methods of determining patient response by measurement of her-2 expression |
| 12/23/2010 | US20100325743 Marks as modifiers of the p53 pathway and methods of use |
| 12/23/2010 | US20100325742 Animal Model Based on Targeted Apoptosis for the Study of Genetic Diseases Such as Parkinson's Disease |
| 12/23/2010 | US20100324835 Method and device for securely storing data |
| 12/23/2010 | US20100324829 Method of selecting hla-dp4 ligands and the applications thereof |
| 12/23/2010 | US20100324828 Sensor device for and a method of sensing magnetic particles |
| 12/23/2010 | US20100324452 Tissue penetration device |
| 12/23/2010 | US20100324450 Apparatus and Method for Separating and Concentrating Fluids Containing Multiple Components |
| 12/23/2010 | US20100324277 Oligomeric compounds comprising 4'-thionucleosides for use in gene modulation |
| 12/23/2010 | US20100324268 Multi-oligomeric or multi--polymeric compositions comprising labeled moieties and binding partners |
| 12/23/2010 | US20100324154 Assessing susceptibility to vascular disorders |
| 12/23/2010 | US20100324125 Proteins derived from white spot syndrome virus and uses thereof |
| 12/23/2010 | US20100324119 Reducing irf4, dusp22, or flj43663 polypeptide expression |
| 12/23/2010 | US20100324114 Methods and kits to detect hereditary angioedema type III |
| 12/23/2010 | US20100323957 Novel assay for inhibitors of egfr |
| 12/23/2010 | US20100323922 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
| 12/23/2010 | US20100323918 Polymer surface functionalization and related applications |
| 12/23/2010 | US20100323915 Porous Substrate Plates And The Use Thereof |
| 12/23/2010 | US20100323913 Purification and Concentration of Proteins and DNA from a Complex Sample Using Isotachophoresis and a Device to Perform the Purification |
| 12/23/2010 | US20100323912 Real-time analytical methods and systems |
| 12/23/2010 | US20100323911 Detection of worsening renal disease in subjects with systemic lupus erythematosus |
| 12/23/2010 | US20100323908 Methods and Compositions For Diagnosing Osteoarthritis In A Feline |
| 12/23/2010 | US20100323907 Frozen cell and tissue microarrays |
| 12/23/2010 | US20100323905 Vhh for the Diagnosis, Prevention and Treatment of Diseases Associated with Protein Aggregates |
| 12/23/2010 | US20100323902 Live-cell signals of pathogen intrusion and methods thereof |
| 12/23/2010 | US20100323870 Apparatus and Method for Separating and Concentrating Fluids Containing Multiple Components |
| 12/23/2010 | US20100323457 Biosensing method using coated magnetic fine particles and biosensing apparatus for biosensing method |
| 12/23/2010 | US20100323456 Endothelin Receptors in Morphine Withdrawal |
| 12/23/2010 | US20100323455 Diagnostic assay for human matrix gla-protein and its use as a biomarker |
| 12/23/2010 | US20100323453 Methods of Using Dyes in Association with Nucleic Acid Staining or Detection and Associated Technology |
| 12/23/2010 | US20100323452 Process for purification of water soluble polymers |
| 12/23/2010 | US20100323451 Method of predicting phospolipidosis inducing properties of a substance |
| 12/23/2010 | US20100323450 System for quantitative measurement of glycohemoglobin and method for measuring glycohemoglobin |
| 12/23/2010 | US20100323425 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 12/23/2010 | US20100323401 General method for generating human antibody responses in vitro |
| 12/23/2010 | US20100323396 Platelet measurement reagent, platelet measurement reagent kit, and platelet measurement method |
| 12/23/2010 | US20100323379 Sleep apnea |
| 12/23/2010 | US20100323377 Biochemical markers for cvd risk assessment |
| 12/23/2010 | US20100323376 Method for Measuring Lipoprotein-Specific Apolipoproteins |
| 12/23/2010 | US20100323375 Agent and method for diagnosis on the occurrence of alzheimer's disease or the tendency to develop alzheimer's disease |